Biologically Active Small Molecules

A cell permeable analog of cAMP that activates PKA with a Ka value of 0.05 &muM more stable to hydrolysis and has increased membrane permeability compared to unmodified cAMP.

A brominated derivative of cAMP that remains long-acting due to its resistance to degradation by cAMP phosphodiesterase activates cAMP-dependent protein kinase, inhibiting growth, decreasing proliferation, increasing differentiation, and inducing

A brominated derivative of cAMP that remains long-acting due to its resistance to degradation by cAMP phosphodiesterase activates cAMP-dependent protein kinase, inhibiting growth, decreasing proliferation, increasing differentiation, and inducing

A brominated derivative of cAMP that remains long-acting due to its resistance to degradation by cAMP phosphodiesterase activates cAMP-dependent protein kinase, inhibiting growth, decreasing proliferation, increasing differentiation, and inducing

A brominated derivative of cAMP that remains long-acting due to its resistance to degradation by cAMP phosphodiesterase activates cAMP-dependent protein kinase, inhibiting growth, decreasing proliferation, increasing differentiation, and inducing

A cell-permeable analog of cGMP that preferentially activates cGMP-dependent protein kinase 1 &microM-0.1 mM inhibits acetylcholine-induced increases in intracellular calcium concentrations.

A cell-permeable analog of cGMP that preferentially activates cGMP-dependent protein kinase 1 &microM-0.1 mM inhibits acetylcholine-induced increases in intracellular calcium concentrations.

A cell-permeable analog of cGMP that preferentially activates cGMP-dependent protein kinase 1 &microM-0.1 mM inhibits acetylcholine-induced increases in intracellular calcium concentrations.

A cell-permeable analog of cGMP that preferentially activates cGMP-dependent protein kinase 1 &microM-0.1 mM inhibits acetylcholine-induced increases in intracellular calcium concentrations.

A brominated derivative of guanosine that has been used to reduce the conformational heterogeneity of RNA to potentially enhance its function reported to activate lymphocytes through an intracellular mechanism to exert immunostimulatory effects.

A brominated derivative of guanosine that has been used to reduce the conformational heterogeneity of RNA to potentially enhance its function reported to activate lymphocytes through an intracellular mechanism to exert immunostimulatory effects.

A brominated derivative of guanosine that has been used to reduce the conformational heterogeneity of RNA to potentially enhance its function reported to activate lymphocytes through an intracellular mechanism to exert immunostimulatory effects.